Skip to main content

and
  1. No Access

    Article

    Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and γ-radiation-induced apoptosis by CD40 activation

    We examined the effects of CD40 activation with dexamethasone (Dex) or 60Co-γ-irradiation on the growth of malignant B cells in vitro, using the human multiple myeloma (MM) cell line, XG2, and the B lymphoma Daud...

    Zhao-Hua Zhou, Z-H. Zhou, Q. Shi, Qin Shi, Jiang-Fang Wang, Yong- **g Chen in Apoptosis (2005)

  2. No Access

    Article

    Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21

    Xuejun Zhang and colleagues report a genome-wide association and replication studies for psoriasis, conducted in Chinese populations. They confirm previous associations in MHC and IL12B to psoriasis susceptibilit...

    Xue-Jun Zhang, Wei Huang, Sen Yang, Liang-Dan Sun, Feng-Yu Zhang in Nature Genetics (2009)

  3. No Access

    Article

    Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC

    Youwen Zhou and Xue-Jun Zhang and colleagues report a genome-wide association study of generalized vitiligo, a common autoimmune disorder characterized by loss of melanocytes and depigmentation. The authors id...

    Cheng Quan, Yun-Qing Ren, Lei-Hong **ang, Liang-Dan Sun, Ai-E Xu in Nature Genetics (2010)

  4. No Access

    Article

    Association analyses identify six new psoriasis susceptibility loci in the Chinese population

    Xue-Jun Zhang and colleagues report genome-wide association analyses identifying six new susceptibility loci in the Chinese population.

    Liang-Dan Sun, Hui Cheng, Zai-**ng Wang, An-** Zhang, Pei-Guang Wang in Nature Genetics (2010)

  5. Article

    Open Access

    Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1

    HBO1 (histone acetyltransferase binding to ORC1) is a histone acetyltransferase (HAT) which could exert oncogenic function in breast cancer. However, the biological role and underlying mechanism of HBO1 in bre...

    Wen-zhong Wang, Hai-ou Liu, Yi-hong Wu in Journal of Experimental & Clinical Cancer … (2010)

  6. No Access

    Article

    MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer

    Resistance to chemotherapy and endocrine therapy as well as targeted drugs is a major problem in treatment of breast cancer. Over the last decades, emerging studies have revealed that extracellular vesicles, w...

    Wei-xian Chen, Shan-liang Zhong, Ming-hua Ji, Meng Pan, Qing Hu in Tumor Biology (2014)

  7. No Access

    Article

    HSF1 functions as a transcription regulator for Dp71 expression

    Heat shock factor 1 (HSF1) is one of the most important transcriptional molecules in the heat shock process; however, HSF1 can also regulate the expression of other proteins. Dystrophin Dp71 is one of the most...

    ** Tan, Sichuang Tan, Hexin Zheng, Meidong Liu in Cell Stress and Chaperones (2015)

  8. No Access

    Article

    A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma

    Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancers in adults, and microRNAs (miRNAs) differentially expressed in ccRCC tumors have been identified and proposed to predict prog...

    Yu-Zheng Ge, Ran Wu, Hui **n, Meng Zhu in Journal of Cancer Research and Clinical On… (2015)

  9. Article

    Open Access

    Distribution and prognosis of uncommon metastases from non-small cell lung cancer

    According to the literature and our experience, the most common sites of non-small cell lung cancer (NSCLC) metastases include the brain, bone, liver, adrenal glands, contralateral lung and distant lymph nodes...

    Fei-Yu Niu, Qing Zhou, **-Ji Yang, Wen-Zhao Zhong, Zhi-Hong Chen, Wei Deng in BMC Cancer (2016)

  10. Article

    Open Access

    Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

    Detecting epidermal growth factor receptor (EGFR) activating mutations in plasma could guide EGFR-tyrosine kinase inhibitor (EGFR-TKI) treatment for advanced non-small cell lung cancer (NSCLC). However, dynamic q...

    Qing Zhou, **-Ji Yang, Zhi-Hong Chen, Xu-Chao Zhang in Journal of Hematology & Oncology (2016)

  11. No Access

    Article

    Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)

    The safety and efficacy of intraoperative chemotherapy in colorectal cancer have not yet been extensively investigated. This randomized control trial was designed to compare the safety and efficacy of intraope...

    Rong-xin Zhang, Jun-zhong Lin, Jian Lei in Journal of Cancer Research and Clinical On… (2017)

  12. Article

    Open Access

    Long-term outcomes of endoscopic submucosal dissection for high-grade dysplasia and early-stage carcinoma in the colorectum

    Colorectal carcinomas (CRCs) arise from premalignant precursors in an adenoma-carcinoma sequence, in which adenoma with high-grade dysplasia (HGD) and early-stage carcinoma are defined as advanced neoplasia. A...

    Tao Chen, Wen-Zheng Qin, Li-Qing Yao, Yun-Shi Zhong, Yi-Qun Zhang in Cancer Communications (2018)

  13. No Access

    Article

    Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm

    The Notch signaling pathway contributes to the pathogenesis of a wide spectrum of human cancers, including hematopoietic malignancies. Its functions are highly dependent on the specific cellular context. Gain-...

    Guangyao Kong, **aona You, Zhi Wen, Yuan-I Chang, Shuiming Qian in Leukemia (2019)

  14. Article

    Open Access

    The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response

    An emerging body of evidence has recently recognized the coexistence of epithelial-mesenchymal transition (EMT) and immune response. However, a systems-level view and survey of the interplay between EMT and im...

    Guangyu Wang, Dandan Xu, Zicheng Zhang, **nhui Li, Jiaqi Shi in npj Precision Oncology (2021)

  15. Article

    Open Access

    MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

    MET amplification plays an important role in the development of non-small-cell lung cancer (NSCLC) either de novo or in resistance to epidermal growth factor receptor tyrosine–kinase inhibitor (EGFR-TKI) settings...

    Lun-** Peng, Guang-Ling Jie, An-Na Li, Si-Yang Liu in Experimental Hematology & Oncology (2021)

  16. Article

    Open Access

    Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

    EMERGING-CTONG 1103 showed improved progression-free survival (PFS) with neoadjuvant erlotinib vs. chemotherapy for patients harbouring EGFR sensibility mutations and R0 resected stage IIIA-N2 non-small cell l...

    Wen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen in Signal Transduction and Targeted Therapy (2023)

  17. Article

    Open Access

    AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer

    The prognostic role of either forkhead box A1 (FOXA1) or anterior gradient 2 (AGR2) in breast cancer has been found separately. Considering that there were interplays between them depending on ER status, we ai...

    Meng Zhou, **ng-li Gan, Yue-xiang Ren, Qian-xin Chen, Yuan-zhong Yang in BMC Cancer (2023)

  18. No Access

    Article

    Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer

    Results of previous studies about the prognostic roles of histone H4 lysine 16 acetylation (H4K16ac) and histone H4 lysine 20 trimethylation (H4K20me3) in breast cancer were inconsistent. Cellular experiments ...

    Bo Wang, Meng Zhou, **ng-li Gan in International Journal of Clinical Oncology (2023)

  19. Article

    Open Access

    Enhanced cellular therapy: revolutionizing adoptive cellular therapy

    Enhanced cellular therapy has emerged as a novel concept following the basis of cellular therapy. This treatment modality applied drugs or biotechnology to directly enhance or genetically modify cells to enhan...

    Meng-Yao Xu, Na Zeng, Chen-Qian Liu, Jian-Xuan Sun in Experimental Hematology & Oncology (2024)